Public filings / BIO on Yahoo Finance (opens in a new tab)
BIO: insider buying, 13F holders, analyst moves
Bio-Rad Laboratories Inc - US
A summary of public filings about Bio-Rad Laboratories Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
3 of our 100 managers hold BIO
Combined reported value $191.7M; 1 sold out since Q1 2026.
Holders among our 100 managers: 3 in Q3 2023, 3 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| First Pacific Advisors | $118.0M | 1.46% | Trimmed |
| Deerfield Company | $66.4M | 0.69% | Unchanged |
| Tudor Investment | $7.3M | 0.03% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.